Switch theme
Sign up to access all valuation multiples
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
2007
918
Last FY Revenue $384M
Last FY EBITDA -$346M
$521M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Concord Medical Services achieved revenue of $384M and an EBITDA of -$346M.
Concord Medical Services expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Concord Medical Services valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $384M | XXX | XXX | XXX |
| Gross Profit | XXX | -$79.2M | XXX | XXX | XXX |
| Gross Margin | XXX | -21% | XXX | XXX | XXX |
| EBITDA | XXX | -$346M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -90% | XXX | XXX | XXX |
| EBIT | XXX | -$532M | XXX | XXX | XXX |
| EBIT Margin | XXX | -139% | XXX | XXX | XXX |
| Net Profit | XXX | -$308M | XXX | XXX | XXX |
| Net Margin | XXX | -80% | XXX | XXX | XXX |
| Net Debt | XXX | $3.5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Concord Medical Services's stock price is $5.
Concord Medical Services has current market cap of $22.5M, and EV of $521M.
See Concord Medical Services trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $521M | $22.5M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Concord Medical Services has market cap of $22.5M and EV of $521M.
Concord Medical Services's trades at 1.4x EV/Revenue multiple, and -1.5x EV/EBITDA.
Equity research analysts estimate Concord Medical Services's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Concord Medical Services's P/E ratio is not available.
See valuation multiples for Concord Medical Services and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22.5M | XXX | $22.5M | XXX | XXX | XXX |
| EV (current) | $521M | XXX | $521M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -1.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialConcord Medical Services's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.5M for the same period.
Concord Medical Services's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Concord Medical Services's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Concord Medical Services and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -90% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 118% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Concord Medical Services acquired XXX companies to date.
Last acquisition by Concord Medical Services was XXXXXXXX, XXXXX XXXXX XXXXXX . Concord Medical Services acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Concord Medical Services founded? | Concord Medical Services was founded in 2007. |
| Where is Concord Medical Services headquartered? | Concord Medical Services is headquartered in United States of America. |
| How many employees does Concord Medical Services have? | As of today, Concord Medical Services has 918 employees. |
| Who is the CEO of Concord Medical Services? | Concord Medical Services's CEO is Dr. Jianyu Yang. |
| Is Concord Medical Services publicy listed? | Yes, Concord Medical Services is a public company listed on NYS. |
| What is the stock symbol of Concord Medical Services? | Concord Medical Services trades under CCM ticker. |
| When did Concord Medical Services go public? | Concord Medical Services went public in 2009. |
| Who are competitors of Concord Medical Services? | Similar companies to Concord Medical Services include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Concord Medical Services? | Concord Medical Services's current market cap is $22.5M |
| Is Concord Medical Services profitable? | Yes, Concord Medical Services is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
